Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Biomarker discovery outsourcing services industry 3600 synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Type trends
2.1.4 Service trends
2.1.5 Therapeutic area trends
2.1.6 End-use trends
Chapter 3 Biomarker Discovery Outsourcing Services Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of chronic diseases
3.2.1.2 Increasing R&D fundings fuels the market growth
3.2.1.3 Increasing focus on personalized medicine and targeted therapies
3.2.1.4 Advancements in high-throughput omics technologies
3.2.1.5 Booming biologics industry
3.2.2 Industry pitfalls & challenges
3.2.2.1 Intellectual property concerns
3.2.2.2 Data security
3.3 Growth potential analysis
3.3.1 By type
3.3.2 By service
3.3.3 By therapeutic area
3.3.4 By end-uses
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis, 2023
4.3 Competitive analysis of major market players, 2023
4.4 Competitive positioning matrix, 20232
4.5 Strategic dashboard, 2023
Chapter 5 Biomarker Discovery Outsourcing Services Market Estimates and Forecast, By Type, 2018-2032 (USD Million)
5.1 Key trends, by type
5.2 Predictive biomarkers
5.3 Prognostic biomarkers
5.4 Safety biomarkers
5.5 Surrogate endpoints
5.6 Other types
Chapter 6 Biomarker Discovery Outsourcing Services Market Estimates and Forecast, By Service, 2018-2032 (USD Million)
6.1 Key trends, by service
6.2 Genomic biomarker services
6.3 Proteomics biomarker services
6.4 Bioinformatics biomarker services
6.5 Other services
Chapter 7 Biomarker Discovery Outsourcing Services Market Estimates and Forecast, By Therapeutic Area, 2018-2032 (USD Million)
7.1 Key trends, by therapeutic area
7.2 Oncology
7.3 Cardiology
7.4 Neurology
7.5 Autoimmune diseases
7.6 Other therapeutic areas
Chapter 8 Biomarker Discovery Outsourcing Services Market Estimates and Forecast, By End-use, 2018-2032 (USD Million)
8.1 Key trends, by end-use
8.2 Pharmaceutical companies
8.3 Biotechnology companies
8.4 Other end-users
Chapter 9 Biomarker Discovery Outsourcing Services Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Bio-Rad Laboratories, Inc.
10.2 Parexel International (MA) Corporation
10.3 Svar Life Science
10.4 Sino Biological, Inc
10.5 ICON plc.
10.6 Integrated DNA Technologies, Inc.
10.7 Almac Group Limited
10.8 REPROCELL Inc.
10.9 Frontage Labs
10.10 Biomcare ApS
10.11 Crown Bioscience
10.12 RayBiotech, Inc.
10.13 Excelra
10.14 Evotec
